LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication. The feature is expected to be published in the July 2026 edition and will include an editorial profile and interview discussing the Company’s healthcare technology initiatives, digital healthcare ecosystem strategy, and ongoing efforts to improve healthcare accessibility throughout Latin America.
The Company noted that it has received a formal invitation from the publisher to participate in a broader editorial feature package expected to include coverage through both ES Salud Magazine and Eva’s Magazine. According to the invitation, the feature is anticipated to be distributed through multiple print, digital, social media, and online publication channels. Management stated that the publication is expected to provide an opportunity to discuss LataMed AI’s evolving healthcare platform while increasing visibility of the Company’s healthcare ecosystem among healthcare professionals, industry participants, and other stakeholders throughout the healthcare sector.
The feature is expected to discuss the Company’s telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions currently under development. The Company noted that the feature is expected to highlight its broader vision of developing an integrated healthcare ecosystem designed to improve accessibility, coordination, and engagement for patients, healthcare providers, and other healthcare stakeholders across emerging markets, while further increasing awareness of the Company’s developing healthcare technology initiatives.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We appreciate the opportunity to share our vision for technology-enabled healthcare solutions and discuss the initiatives we are currently advancing throughout Latin America. We believe healthcare accessibility, coordination, and patient engagement remain important challenges across many markets, and we welcome opportunities to participate in industry discussions regarding the role of technology in addressing those challenges. We also believe opportunities to engage with healthcare-focused audiences help increase awareness of our broader healthcare ecosystem strategy and the technologies we are developing to support patients and providers throughout Latin America.”
The Company expects the feature to be published during July 2026 and intends to provide additional updates once publication details have been finalized, including information regarding publication dates, online availability, print distribution, and access through the publication's online digital channels. For additional information, please visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This announcement matters because it signals LataMed AI's strategic effort to gain visibility and credibility within the healthcare industry, potentially attracting partners and investors as it advances its digital health platform in emerging markets. The feature in a reputable healthcare magazine could enhance the Company's profile among key stakeholders, supporting its mission to address healthcare accessibility challenges through technology.
